Opus Genetics, Inc. (IRD) Free Cash Flow
Opus Genetics, Inc. (IRD) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$13.55M |
| 2017-12-31 | -$31.24M |
| 2018-12-31 | -$18.88M |
| 2019-12-31 | -$3.62M |
| 2020-12-31 | -$6.80M |
| 2021-12-31 | -$19.37M |
| 2022-12-31 | $14.31M |
| 2023-12-31 | -$1.11M |
| 2024-12-31 | -$25.58M |
| 2025-12-31 | -$35.25M |
How IRD compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ATOS | Atossa Therapeutics Inc. | -$29.79M |
| VERU | Veru Inc. | -$30.04M |
| CRVS | Corvus Pharmaceuticals Inc. | -$32.97M |
| TENX | — | -$35.80M |
| XBIT | XBiotech Inc. | -$40.21M |
These are five companies in the same sector as IRD with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Opus Genetics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("IRD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IRD | $4.05 | -1.70% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 |